Assuntos: LINFOMA, QUIMIOTERAPIA, QUIMIOTERÁPICOS, EVENTO ADVERSO A MEDICAMENTO, NEOPLASIAS MAMÁRIAS
ABNT
VERONESE, Pedro e HAJJAR, Ludhmila Abrahao. Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer. PLOS ONE, v. 13, n. 5, 2018Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0196763. Acesso em: 16 nov. 2025.APA
Veronese, P., & Hajjar, L. A. (2018). Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer. PLOS ONE, 13( 5). doi:10.1371/journal.pone.0196763NLM
Veronese P, Hajjar LA. Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer [Internet]. PLOS ONE. 2018 ; 13( 5):[citado 2025 nov. 16 ] Available from: https://doi.org/10.1371/journal.pone.0196763Vancouver
Veronese P, Hajjar LA. Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer [Internet]. PLOS ONE. 2018 ; 13( 5):[citado 2025 nov. 16 ] Available from: https://doi.org/10.1371/journal.pone.0196763